Akums Pharma, a top pharmaceutical company in India, has received approval from the Central Drugs Standard Control Organization (CDSCO) for a new drug to treat diabetes. This drug is a combination of three medicines: sitagliptin, pioglitazone, and metformin. It is the first of its kind in India.
This approval is a big achievement for Akums Pharma and for people with diabetes in India. Diabetes is a long-term illness that affects many people around the world, and it can lead to serious health problems and even death. The combination of sitagliptin, pioglitazone, and metformin has been proven to be effective in controlling blood sugar levels in diabetes patients.
The special thing about this drug is that it combines all three medicines into one tablet. This makes it more convenient for patients because they only need to take one tablet instead of three. It also makes it easier for patients to remember to take their medication. The combination of these medicines may also work better together and have stronger effects.
The approval of this drug by CDSCO is a major step forward in diabetes treatment in India. It provides a new and convenient option for patients and has the potential to improve blood sugar control and reduce the risk of complications.
About Akums Pharma: Akums Pharma is a leading pharmaceutical company in India that focuses on creating and manufacturing innovative generic medicines. They have a strong history of developing new treatments and have a wide range of products. Akums Pharma is dedicated to providing high-quality medicines that meet the needs of patients and healthcare professionals.
About Diabetes: Diabetes is a chronic illness that affects how the body processes sugar in the blood. Sugar is the body’s main source of energy, so it’s important to keep it at a healthy level. Diabetes can lead to serious health issues like heart disease, stroke, blindness, and kidney failure.
There are two main types of diabetes: type 1 and type 2. Type 1 diabetes is an autoimmune disease where the body’s immune system attacks the cells in the pancreas that make insulin. Type 2 diabetes is caused by a mix of factors such as genetics, lifestyle, and being overweight.
There is no cure for diabetes, but it can be managed with lifestyle changes, medication, and insulin therapy. Making healthy choices in diet, exercise, and weight management can help control diabetes. Medications, including pills and insulin injections, can also be used to manage the condition.
In conclusion, the approval of Akums Pharma’s new diabetes drug is a major milestone in the treatment of diabetes in India. It offers a convenient treatment option for patients and has the potential to improve blood sugar control and reduce the risk of complications.
